These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8861748)

  • 1. Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells.
    Crocker IC; Townley RG; Khan MM
    Immunopharmacology; 1996 Mar; 31(2-3):223-35. PubMed ID: 8861748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells.
    Coqueret O; Boichot E; Lagente V
    Clin Exp Allergy; 1997 Jul; 27(7):816-23. PubMed ID: 9249275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of phosphodiesterase inhibitors on IL-13 release from peripheral blood mononuclear cells.
    Yoshida N; Shimizu Y; Kitaichi K; Hiramatsu K; Takeuchi M; Ito Y; Kume H; Yamaki K; Suzuki R; Shibata E; Hasegawa T; Takagi K
    Clin Exp Immunol; 2001 Dec; 126(3):384-9. PubMed ID: 11737051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase type 4 inhibitors, but not glucocorticoids, are more potent in suppression of cytokine secretion by mononuclear cells from atopic than nonatopic donors.
    Crocker IC; Ohia SE; Church MK; Townley RG
    J Allergy Clin Immunol; 1998 Nov; 102(5):797-804. PubMed ID: 9819297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phosphodiesterase inhibition on IL-4 and IL-5 production of the murine TH2-type T cell clone D10.G4.1.
    Schmidt J; Hatzelmann A; Fleissner S; Heimann-Weitschat I; Lindstaedt R; Szelenyi I
    Immunopharmacology; 1995 Sep; 30(3):191-8. PubMed ID: 8557518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
    J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-5 production by peripheral blood mononuclear cells of asthmatic patients is suppressed by T-440: relation to phosphodiesterase inhibition.
    Kaminuma O; Mori A; Suko M; Kikkawa H; Ikezawa K; Okudaira H
    J Pharmacol Exp Ther; 1996 Oct; 279(1):240-6. PubMed ID: 8858999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors.
    Nakata A; Ogawa K; Sasaki T; Koyama N; Wada K; Kotera J; Kikkawa H; Omori K; Kaminuma O
    Clin Exp Immunol; 2002 Jun; 128(3):460-6. PubMed ID: 12067300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Th1- and Th2-like cytokine production from mitogen-stimulated human peripheral blood mononuclear cells by phosphodiesterase inhibitors.
    Yoshimura T; Nagao T; Nakao T; Watanabe S; Usami E; Kobayashi J; Yamazaki F; Tanaka H; Inagaki N; Nagai H
    Gen Pharmacol; 1998 Feb; 30(2):175-80. PubMed ID: 9502171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation.
    Gantner F; Götz C; Gekeler V; Schudt C; Wendel A; Hatzelmann A
    Br J Pharmacol; 1998 Mar; 123(6):1031-8. PubMed ID: 9559883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition.
    Chan SC; Li SH; Hanifin JM
    J Invest Dermatol; 1993 May; 100(5):681-4. PubMed ID: 8388009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-5 production by bronchoalveolar lavage and peripheral blood mononuclear cells in asthma and atopy.
    Tang C; Rolland JM; Ward C; Quan B; Walters EH
    Eur Respir J; 1997 Mar; 10(3):624-32. PubMed ID: 9072996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis.
    Kanda N; Enomoto U; Watanabe S
    J Invest Dermatol; 2001 Dec; 117(6):1635-46. PubMed ID: 11886533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modulation of cytokine production from human mononuclear cells by several agents].
    Yoshimura T
    Yakugaku Zasshi; 2000 Dec; 120(12):1277-90. PubMed ID: 11193379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells.
    Yoshimura T; Kurita C; Nagao T; Usami E; Nakao T; Watanabe S; Kobayashi J; Yamazaki F; Tanaka H; Nagai H
    Gen Pharmacol; 1997 Oct; 29(4):633-8. PubMed ID: 9352314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased leukocyte sensitivity to phosphodiesterase inhibitors in atopic dermatitis: tachyphylaxis after theophylline therapy.
    Giustina TA; Chan SC; Thiel ML; Baker JW; Hanifin JM
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 1):252-7. PubMed ID: 6088608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
    Chan SC; Hanifin JM
    J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study.
    Gantner F; Tenor H; Gekeler V; Schudt C; Wendel A; Hatzelmann A
    J Allergy Clin Immunol; 1997 Oct; 100(4):527-35. PubMed ID: 9338548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of anti-CD3-induced interleukin-4 and interleukin-5 release from splenocytes of Mesocestoides corti-infected BALB/c mice by phosphodiesterase 4 inhibitors.
    Souness JE; Houghton C; Sardar N; Withnall MT
    Biochem Pharmacol; 1999 Sep; 58(6):991-9. PubMed ID: 10509751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of theophylline and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO 20-1724) on protein secretion from rat parotid gland.
    Afari G; Tenenhouse A; Vachon C
    Br J Pharmacol; 1982 Nov; 77(3):405-11. PubMed ID: 6291691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.